RetiSEM: Generalising Causal Models for Fragmented Biomedical Data

What Happened

Researchers have introduced RetiSEM, a novel framework for learning causal models from fragmented biomedical datasets. The approach extends structural equation modeling (SEM) with domain-specific constraints to handle the pervasive problem of missing or unaligned variables across clinical records, molecular assays, and imaging modalities. The paper, posted on arXiv, addresses a fundamental bottleneck in biomedical AI: causal inference when no single dataset contains all relevant variables.

Why It Matters

Biomedical data is notoriously fragmented. A patient’s electronic health record might contain lab results and diagnoses, but lack genomic sequencing. A separate research cohort might have deep molecular profiling but sparse clinical follow-up. Traditional causal discovery algorithms assume complete observations or at least overlapping variable sets across samples—an assumption that rarely holds in practice.

RetiSEM’s key innovation lies in integrating domain knowledge directly into the SEM optimization process. By constraining the model structure using known biological pathways, tissue-specific regulatory networks, or clinical hierarchies, the framework can recover causal relationships even when variables are never jointly observed. This is a significant departure from purely data-driven approaches that require full covariance matrices.

The implications extend beyond biomedicine. Any domain with heterogeneous data sources—such as climate science, economics, or social science—faces similar fragmentation. RetiSEM provides a template for embedding expert knowledge into causal discovery, reducing reliance on massive, perfectly aligned datasets.

Implications for AI Practitioners

For machine learning engineers and data scientists working in healthcare, RetiSEM offers a practical tool for causal modeling under real-world constraints. Practitioners can now:

• Leverage partial data: Instead of discarding incomplete records or merging datasets with lossy imputation, RetiSEM allows modeling with whatever variables are available across different cohorts.
• Inject domain priors: The framework’s constraint mechanism means that biological or clinical expertise can guide the search for causal structures, reducing false positives from spurious correlations.
• Improve generalizability: Causal models learned under fragmentation are more likely to transfer across institutions or populations, since they capture invariant mechanisms rather than dataset-specific patterns.

However, practitioners should note that domain-constrained SEM requires careful specification of constraints—poorly chosen priors can bias results. The approach also demands computational resources for high-dimensional variable sets, though the authors suggest optimizations for sparse biological networks.

Key Takeaways

• RetiSEM addresses a critical gap in causal discovery by enabling model learning from fragmented biomedical data where variables are not jointly observed.
• The framework integrates domain-specific constraints into structural equation modeling, allowing causal inference without requiring complete datasets.
• For AI practitioners, this means more robust causal models in healthcare and other fields with heterogeneous, incomplete data sources.
• Successful deployment requires careful domain knowledge engineering and computational planning, but offers substantial gains in real-world applicability over standard causal discovery methods.